FYI, from The Street on 10/3/14
Rockwell Medical Technologies (NASDAQ: RMTI) announced that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (NYSE: BAX), to commercialize Rockwell's hemodialysis concentrate product line in the U.S. and in select overseas markets.
Under the terms of the agreement, Baxter will become the exclusive distributor of Rockwell's hemodialysis concentrate and ancillary products in the U.S. and selected foreign countries for an initial term of 10 years. Baxter can extend the agreement for two additional 5-year terms upon meeting certain sales targets, coupled with a $7.5 million payment related to the first extension. Baxter will purchase products from Rockwell at a pre-determined gross margin-based price per unit and is required to meet minimum annual purchase levels in order to retain their exclusive rights. Baxter will leverage Rockwell's unique distribution operations in order to provide specialized customer and delivery service for concentrates, covering Rockwell's costs for these services. Rockwell will retain sales, marketing and distribution rights for its hemodialysis concentrate products in certain foreign
countries in which it has an established commercial presence.
So Capt'n, when they report numbers and you are proven wrong, I am sure you will man up and admit that you are wrong and mosey on into the sunset, never to darken this board again. And if I am wrong, I will do the same. What do you say short stuff, you man enough to make the deal?